These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 30146959)
41. Promoting Antibacterial Drug Development: Select Policies and Challenges. Sertkaya A; Jessup A; Wong HH Appl Health Econ Health Policy; 2017 Feb; 15(1):113-118. PubMed ID: 27601239 [TBL] [Abstract][Full Text] [Related]
42. Incentivising innovation in antibiotic drug discovery and development: progress, challenges and next steps. Simpkin VL; Renwick MJ; Kelly R; Mossialos E J Antibiot (Tokyo); 2017 Dec; 70(12):1087-1096. PubMed ID: 29089600 [TBL] [Abstract][Full Text] [Related]
43. Innovation of novel antibiotics: an economic perspective. McKellar MR; Fendrick AM Clin Infect Dis; 2014 Oct; 59 Suppl 3():S104-7. PubMed ID: 25261536 [TBL] [Abstract][Full Text] [Related]
44. A three-step plan for antibiotics. Nature; 2014 May; 509(7502):533. PubMed ID: 24877183 [No Abstract] [Full Text] [Related]
45. Report urges controversial 'delinkage' to foster new antibiotics. Holmes D Nat Med; 2014 Apr; 20(4):320. PubMed ID: 24710363 [No Abstract] [Full Text] [Related]
46. Financing Pull Mechanisms for Antibiotic-Related Innovation: Opportunities for Europe. Årdal C; Lacotte Y; Ploy MC Clin Infect Dis; 2020 Nov; 71(8):1994-1999. PubMed ID: 32060511 [TBL] [Abstract][Full Text] [Related]
47. The global need for effective antibiotics: challenges and recent advances. Högberg LD; Heddini A; Cars O Trends Pharmacol Sci; 2010 Nov; 31(11):509-15. PubMed ID: 20843562 [TBL] [Abstract][Full Text] [Related]
48. Wild-card patent extensions as a means to incentivize research and development of antibiotics. Sonderholm J J Law Med Ethics; 2009; 37(2):240-6. PubMed ID: 19493069 [TBL] [Abstract][Full Text] [Related]
49. Evaluating for-profit public benefit corporations as an additional structure for antibiotic development and commercialization. Outterson K; Rex JH Transl Res; 2020 Jun; 220():182-190. PubMed ID: 32165059 [TBL] [Abstract][Full Text] [Related]
50. Antibiotics: the changing regulatory and pharmaceutical industry paradigm. Bax R; Green S J Antimicrob Chemother; 2015 May; 70(5):1281-4. PubMed ID: 25634991 [TBL] [Abstract][Full Text] [Related]
51. Public funding of clinical-stage antibiotic development in the United States and European Union. Eichberg MJ Health Secur; 2015; 13(3):156-65. PubMed ID: 26042859 [TBL] [Abstract][Full Text] [Related]
52. New business models for antibiotic innovation. So AD; Shah TA Ups J Med Sci; 2014 May; 119(2):176-80. PubMed ID: 24646116 [TBL] [Abstract][Full Text] [Related]
53. A systematic review and critical assessment of incentive strategies for discovery and development of novel antibiotics. Renwick MJ; Brogan DM; Mossialos E J Antibiot (Tokyo); 2016 Feb; 69(2):73-88. PubMed ID: 26464014 [TBL] [Abstract][Full Text] [Related]
54. Repairing the broken market for antibiotic innovation. Outterson K; Powers JH; Daniel GW; McClellan MB Health Aff (Millwood); 2015 Feb; 34(2):277-85. PubMed ID: 25646108 [TBL] [Abstract][Full Text] [Related]
55. The 10 x '20 Initiative: pursuing a global commitment to develop 10 new antibacterial drugs by 2020. Infectious Diseases Society of America Clin Infect Dis; 2010 Apr; 50(8):1081-3. PubMed ID: 20214473 [TBL] [Abstract][Full Text] [Related]
56. Preserving the 'commons': addressing the sustainable use of antibiotics through an economic lens. Morel CM; Edwards SE; Harbarth S Clin Microbiol Infect; 2017 Oct; 23(10):718-722. PubMed ID: 28811243 [TBL] [Abstract][Full Text] [Related]
58. Resistance diagnosis and the changing economics of antibiotic discovery. McAdams D Ann N Y Acad Sci; 2017 Jan; 1388(1):18-25. PubMed ID: 28072904 [TBL] [Abstract][Full Text] [Related]
59. Commentary: How to encourage more diagnostics for infectious diseases. Powers JH BMJ; 2016 Sep; 354():i4744. PubMed ID: 27604999 [No Abstract] [Full Text] [Related]
60. Incentives for developing new antibiotics or antimicrobial strategies. Dahle UR; Petersen FC BMJ; 2013 Apr; 346():f2136. PubMed ID: 23568793 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]